- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Cancer in Norway
Total 855 results
-
AllerganCompletedOveractive BladderUnited States
-
PfizerCompletedUrinary Bladder, OveractivePortugal, Spain, Turkey, Finland, Germany, Norway, Sweden, Slovakia, Italy, Austria, United Kingdom, Belgium, Denmark, Israel, Switzerland
-
Haukeland University HospitalUniversity of Tromso; Norwegian Foundation for Health and RehabilitationUnknownMyocardial Infarction | Cancer | Cerebrovascular StrokeNorway
-
University Hospital of North NorwayCompletedMelanoma (Skin) | Actinic Keratoses | Non-melanoma Skin CancerNorway
-
Oslo University HospitalUniversity of Oslo; Albert Einstein College of Medicine; University of Bergen; University... and other collaboratorsCompleted
-
Per PfeifferOdense University HospitalCompletedFLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS TumorMetastatic Colorectal CancerDenmark, Norway, Sweden
-
Sykehuset TelemarkTerminatedColorectal Cancer | Inflammatory Bowel Disease | Irritable ColonNorway
-
Targovax ASACompletedPancreatic Cancer, ResectedNorway, Spain, United Kingdom
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
Oslo University HospitalUllevaal University Hospital; St. Olavs HospitalCompletedDepression | Pain | Fatigue | Lung Cancer | BreathlessnessNorway
-
Norwegian University of Science and TechnologyOslo University Hospital; Copenhagen University Hospital at Herlev; University... and other collaboratorsCompletedCancer | CachexiaNorway, United Kingdom
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Norway
-
PfizerCompletedUrinary Bladder, OveractiveAustralia, France, Colombia, Germany, Canada, Finland, Slovakia, Spain, Switzerland, Italy, Chile, Greece, Latvia, Norway, Poland, United Kingdom
-
Anna MartlingActive, not recruitingColorectal CancerSweden, Norway
-
Impatients N.V. trading as myTomorrowsInmunotek S.L.No longer availableUrinary Tract Infections | Bladder Infection | Recurrent Urinary Tract Infection | Urinary Tract Infection Bacterial | Chronic Urinary Tract InfectionCzechia, Denmark, Serbia, France, Germany, Turkey, Belgium, Finland, Luxembourg, Netherlands, Norway, Romania, Slovakia, Slovenia, Sweden
-
Haukeland University HospitalCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary IncontinenceUnited States
-
Oslo University HospitalRecruitingClear Cell Renal Cell Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Melanoma Stage IV | Cutaneous Squamous Cell Carcinoma | MSI-HighNorway
-
Lytix Biopharma ASICON plc; TheradexCompletedMelanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast CancerUnited Kingdom, France, Norway, Belgium, Italy
-
Valencia Technologies CorporationActive, not recruitingOveractive Bladder | Urge Incontinence | Urinary Urge Incontinence | Incontinence, UrinaryUnited States
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsRecruitingRecurrent Prostate Cancer | Metastatic Prostate CancerFinland, Norway, Estonia, Denmark
-
University Hospital of North NorwayOdense University Hospital; Oslo University Hospital; Rigshospitalet, Denmark; University... and other collaboratorsActive, not recruitingNon-Small Cell Lung CancerNorway, Denmark
-
Urovant Sciences GmbHActive, not recruitingOveractive BladderUnited States
-
Oslo University HospitalAstraZenecaActive, not recruitingCancer | NSCLC | Non Small Cell Lung Cancer | NSCLC, Stage III | Non Small Cell Lung Cancer Stage IIINorway, Finland, Lithuania, Estonia
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Sorlandet Hospital HFErasmus Medical Center; South-Eastern Norway Regional Health Authority; Maria...CompletedPain | Colorectal Cancer | Colorectal Polyps | Colorectal AdenomasNorway, Poland
-
Sorlandet Hospital HFUppsala University; University of AgderRecruitingCervical Cancer | Gynecologic Cancer | Ovarian Cancer | Vulvar Cancer | Endometrial Cancer | Gynecologic NeoplasmNorway
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary IncontinenceUnited States
-
BayerCompletedBreast Cancer | Bone MetastasesBelgium, United Kingdom, Norway
-
Åslaug HellandBristol-Myers Squibb; Oslo University Hospital; Ultimovacs ASAActive, not recruitingCancer | Mesothelioma | Mesotheliomas Pleural | Cancer of Lung | Cancer, Lung | Mesothelioma; Pleura | Mesothelioma; LungNorway, Denmark, Sweden, Spain, Australia
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Helse Stavanger HFUniversity Hospital of North Norway; Sorlandet Hospital HF; St. Olavs Hospital; University Hospital, Akershus and other collaboratorsTerminated
-
Oslo University HospitalVestre Viken Hospital Trust; University Hospital of North Norway; Ostfold Hospital... and other collaboratorsRecruitingCancer MetastaticNorway
-
PfizerCompletedUrinary Bladder, OveractiveCanada, United States, Germany, Russian Federation, Czechia, Egypt, Bulgaria, Finland, Hungary, Korea, Republic of, Mexico, Poland, South Africa, Sweden, Ukraine
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
Astellas Pharma Europe B.V.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases | Urological Manifestations | Signs and SymptomsBelarus, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder DiseasesGreece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
-
Oslo University HospitalNorwegian Cancer Society; KlinbeforskActive, not recruitingBreast Cancer | Breast Neoplasms | Hormone Receptor Positive TumorNorway
-
Nuvance HealthRecruitingPancreatic Neoplasms | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV | Pancreatic Cancer Stage IIIUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway
-
Oslo University HospitalSykehuset TelemarkRecruitingCancer | Cancer PainNorway, Italy, United Kingdom
-
Per PfeifferMerck Serono International SACompleted
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveAustralia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
-
Haukeland University HospitalPfizer; AstraZeneca; Helse VestActive, not recruitingBreast CancerNorway
-
King's College LondonHospices Civils de Lyon; University of Bergen; Fondazione IRCCS Istituto Nazionale... and other collaboratorsRecruitingCancerDenmark, United Kingdom, France, Italy, Norway
-
Eli Lilly and CompanyCompletedSmall Cell Lung Cancer | Non Small Cell Lung CancerRomania, Norway, Denmark, Poland, Sweden
-
Community Cancer Center, Normal, IllinoisUnknownProstate Cancer | Prostate Neoplasm | Cancer of the ProstateUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Ureter Cancer AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Locally Advanced Ureter Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Localized Renal Pelvis and Ureter Urothelial Carcinoma | Stage II Bladder... and other conditionsUnited States, Guam